Charles Schwab Investment Management Inc. Reduces Stock Position in Bath & Body Works, Inc. $BBWI

Key Points

• Charles Schwab Investment Management Inc. decreased its holdings in Bath & Body Works by 9.8%, owning approximately 1.54 million shares worth $46.6 million after selling over 167,000 shares in the first quarter.
• Analysts have varying opinions on Bath & Body Works, with Wells Fargo upgrading the stock to an "overweight" rating and raising its price target from $40 to $44, while Barclays lowered its target from $35 to $30 with an "equal weight" rating.
• The company recently declared a quarterly dividend of $0.20 per share, indicating a yield of 2.8%, and a dividend payout ratio of 21.33%.

Charles Schwab Investment Management Inc. lowered its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 9.8% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 1,537,496 shares of the company's stock after selling 167,129 shares during the period. Charles Schwab Investment Management Inc. owned about 0.72% of Bath & Body Works worth $46,617,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of BBWI. LPL Financial LLC raised its stake in shares of Bath & Body Works by 48.3% during the 4th quarter. LPL Financial LLC now owns 26,117 shares of the company's stock valued at $1,013,000 after buying an additional 8,511 shares during the last quarter. Envestnet Asset Management Inc. increased its stake in shares of Bath & Body Works by 21.7% in the 4th quarter. Envestnet Asset Management Inc. now owns 168,736 shares of the company's stock valued at $6,542,000 after purchasing an additional 30,042 shares in the last quarter. Invesco Ltd. increased its stake in shares of Bath & Body Works by 22.6% in the 4th quarter. Invesco Ltd. now owns 711,664 shares of the company's stock valued at $27,591,000 after purchasing an additional 130,972 shares in the last quarter. Mariner LLC increased its stake in shares of Bath & Body Works by 14.1% in the 4th quarter. Mariner LLC now owns 23,366 shares of the company's stock valued at $906,000 after purchasing an additional 2,887 shares in the last quarter. Finally, Marshall Wace LLP purchased a new position in shares of Bath & Body Works in the 4th quarter valued at about $628,000. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI traded down $0.2190 during trading on Thursday, reaching $29.4010. The stock had a trading volume of 3,255,996 shares, compared to its average volume of 4,687,182. The business has a fifty day moving average price of $30.19 and a 200-day moving average price of $31.08. The stock has a market cap of $6.22 billion, a PE ratio of 7.84, a PEG ratio of 0.99 and a beta of 1.54. Bath & Body Works, Inc. has a 1-year low of $24.94 and a 1-year high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.47 by $0.02. The firm had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.42 billion. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%.The business's revenue was up 2.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.38 earnings per share. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. Sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 5th. Stockholders of record on Friday, August 22nd will be given a $0.20 dividend. The ex-dividend date is Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.7%. Bath & Body Works's dividend payout ratio is 21.33%.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. JPMorgan Chase & Co. lifted their price target on Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a research note on Monday, July 28th. Morgan Stanley cut their price target on Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a research note on Tuesday, May 6th. UBS Group lifted their price target on Bath & Body Works from $32.00 to $36.00 and gave the company a "neutral" rating in a research note on Tuesday, May 20th. Telsey Advisory Group restated an "outperform" rating and issued a $38.00 price target on shares of Bath & Body Works in a research note on Thursday. Finally, The Goldman Sachs Group cut their price target on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research note on Friday, May 30th. Fourteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, Bath & Body Works currently has a consensus rating of "Moderate Buy" and a consensus price target of $42.06.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.